Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
378.82
|
404.88
|
387.38
|
384.25
|
393.69
|
393.42
|
|
|
82 090 136.44
|
6 617.00
|
377.25
|
394.86
|
375.50
|
371.01
|
390.87
|
383.34
|
|
|
88 598 864.82
|
5 569.00
|
362.63
|
394.87
|
374.36
|
371.75
|
377.06
|
375.50
|
|
|
42 001 774.91
|
4 095.00
|
362.71
|
564.65
|
370.82
|
370.63
|
379.34
|
375.29
|
|
|
67 538 148.28
|
5 529.00
|
357.60
|
373.82
|
370.815
|
366.72
|
375.795
|
372.80
|
|
|
104 942 173.05
|
7 319.00
|
369.00
|
377.80
|
371.11
|
367.165
|
377.78
|
368.60
|
|
|
113 611 213.30
|
7 384.00
|
365.77
|
383.00
|
380.85
|
372.68
|
380.85
|
375.00
|
|
|
100 084 366.56
|
5 839.00
|
362.90
|
378.00
|
368.69
|
368.69
|
377.94
|
375.08
|
|
|
127 306 669.51
|
8 592.00
|
359.15
|
378.00
|
362.93
|
359.83
|
370.80
|
368.75
|
|
|
122 871 400.85
|
7 557.00
|
179.89
|
378.00
|
360.38
|
357.55
|
362.535
|
360.23
|
|
|
119 249 651.68
|
6 843.00
|
Argenx S.E., a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer.